Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting

Andrea K. Miyahira, Adam Sharp, Leigh Ellis, Jennifer Jones, Salma Kaochar, H. Benjamin Larman, David A. Quigley, Huihui Ye, Jonathan W. Simons, Kenneth J. Pienta, Howard R. Soule

Research output: Contribution to journalReview article

Abstract

Introduction: The 2019 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, “Prostate Cancer Research: The Next Generation,” was held 20 to 23 June, 2019, in Los Angeles, California. Methods: The CHPCA Meeting is an annual conference held by the Prostate Cancer Foundation, that is uniquely structured to stimulate intense discussion surrounding topics most critical to accelerating prostate cancer research and the discovery of new life-extending treatments for patients. The 7th Annual CHPCA Meeting was attended by 86 investigators and concentrated on many of the most promising new treatment opportunities and next-generation research technologies. Results: The topics of focus at the meeting included: new treatment strategies and novel agents for targeted therapies and precision medicine, new treatment strategies that may synergize with checkpoint immunotherapy, next-generation technologies that visualize tumor microenvironment (TME) and molecular pathology in situ, multi-omics and tumor heterogeneity using single cells, 3D and TME models, and the role of extracellular vesicles in cancer and their potential as biomarkers. Discussion: This meeting report provides a comprehensive summary of the talks and discussions held at the 2019 CHPCA Meeting, for the purpose of globally disseminating this knowledge and ultimately accelerating new treatments and diagnostics for patients with prostate cancer.

Original languageEnglish (US)
Pages (from-to)113-132
Number of pages20
JournalProstate
Volume80
Issue number2
DOIs
StatePublished - Feb 1 2020

Fingerprint

Prostatic Neoplasms
Research
Tumor Microenvironment
Therapeutics
Technology
Cellular Microenvironment
Precision Medicine
Molecular Pathology
Los Angeles
Immunotherapy
Neoplasms
Biomarkers
Research Personnel

Keywords

  • artificial intelligence
  • cancer immunotherapy
  • precision medicine
  • therapeutics
  • tumor genomics

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Miyahira, A. K., Sharp, A., Ellis, L., Jones, J., Kaochar, S., Larman, H. B., ... Soule, H. R. (2020). Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting. Prostate, 80(2), 113-132. https://doi.org/10.1002/pros.23934

Prostate cancer research : The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting. / Miyahira, Andrea K.; Sharp, Adam; Ellis, Leigh; Jones, Jennifer; Kaochar, Salma; Larman, H. Benjamin; Quigley, David A.; Ye, Huihui; Simons, Jonathan W.; Pienta, Kenneth J.; Soule, Howard R.

In: Prostate, Vol. 80, No. 2, 01.02.2020, p. 113-132.

Research output: Contribution to journalReview article

Miyahira, AK, Sharp, A, Ellis, L, Jones, J, Kaochar, S, Larman, HB, Quigley, DA, Ye, H, Simons, JW, Pienta, KJ & Soule, HR 2020, 'Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting', Prostate, vol. 80, no. 2, pp. 113-132. https://doi.org/10.1002/pros.23934
Miyahira, Andrea K. ; Sharp, Adam ; Ellis, Leigh ; Jones, Jennifer ; Kaochar, Salma ; Larman, H. Benjamin ; Quigley, David A. ; Ye, Huihui ; Simons, Jonathan W. ; Pienta, Kenneth J. ; Soule, Howard R. / Prostate cancer research : The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting. In: Prostate. 2020 ; Vol. 80, No. 2. pp. 113-132.
@article{7ac2eb8a8599446cb67127c2ec2e8b68,
title = "Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting",
abstract = "Introduction: The 2019 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, “Prostate Cancer Research: The Next Generation,” was held 20 to 23 June, 2019, in Los Angeles, California. Methods: The CHPCA Meeting is an annual conference held by the Prostate Cancer Foundation, that is uniquely structured to stimulate intense discussion surrounding topics most critical to accelerating prostate cancer research and the discovery of new life-extending treatments for patients. The 7th Annual CHPCA Meeting was attended by 86 investigators and concentrated on many of the most promising new treatment opportunities and next-generation research technologies. Results: The topics of focus at the meeting included: new treatment strategies and novel agents for targeted therapies and precision medicine, new treatment strategies that may synergize with checkpoint immunotherapy, next-generation technologies that visualize tumor microenvironment (TME) and molecular pathology in situ, multi-omics and tumor heterogeneity using single cells, 3D and TME models, and the role of extracellular vesicles in cancer and their potential as biomarkers. Discussion: This meeting report provides a comprehensive summary of the talks and discussions held at the 2019 CHPCA Meeting, for the purpose of globally disseminating this knowledge and ultimately accelerating new treatments and diagnostics for patients with prostate cancer.",
keywords = "artificial intelligence, cancer immunotherapy, precision medicine, therapeutics, tumor genomics",
author = "Miyahira, {Andrea K.} and Adam Sharp and Leigh Ellis and Jennifer Jones and Salma Kaochar and Larman, {H. Benjamin} and Quigley, {David A.} and Huihui Ye and Simons, {Jonathan W.} and Pienta, {Kenneth J.} and Soule, {Howard R.}",
year = "2020",
month = "2",
day = "1",
doi = "10.1002/pros.23934",
language = "English (US)",
volume = "80",
pages = "113--132",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Prostate cancer research

T2 - The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting

AU - Miyahira, Andrea K.

AU - Sharp, Adam

AU - Ellis, Leigh

AU - Jones, Jennifer

AU - Kaochar, Salma

AU - Larman, H. Benjamin

AU - Quigley, David A.

AU - Ye, Huihui

AU - Simons, Jonathan W.

AU - Pienta, Kenneth J.

AU - Soule, Howard R.

PY - 2020/2/1

Y1 - 2020/2/1

N2 - Introduction: The 2019 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, “Prostate Cancer Research: The Next Generation,” was held 20 to 23 June, 2019, in Los Angeles, California. Methods: The CHPCA Meeting is an annual conference held by the Prostate Cancer Foundation, that is uniquely structured to stimulate intense discussion surrounding topics most critical to accelerating prostate cancer research and the discovery of new life-extending treatments for patients. The 7th Annual CHPCA Meeting was attended by 86 investigators and concentrated on many of the most promising new treatment opportunities and next-generation research technologies. Results: The topics of focus at the meeting included: new treatment strategies and novel agents for targeted therapies and precision medicine, new treatment strategies that may synergize with checkpoint immunotherapy, next-generation technologies that visualize tumor microenvironment (TME) and molecular pathology in situ, multi-omics and tumor heterogeneity using single cells, 3D and TME models, and the role of extracellular vesicles in cancer and their potential as biomarkers. Discussion: This meeting report provides a comprehensive summary of the talks and discussions held at the 2019 CHPCA Meeting, for the purpose of globally disseminating this knowledge and ultimately accelerating new treatments and diagnostics for patients with prostate cancer.

AB - Introduction: The 2019 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, “Prostate Cancer Research: The Next Generation,” was held 20 to 23 June, 2019, in Los Angeles, California. Methods: The CHPCA Meeting is an annual conference held by the Prostate Cancer Foundation, that is uniquely structured to stimulate intense discussion surrounding topics most critical to accelerating prostate cancer research and the discovery of new life-extending treatments for patients. The 7th Annual CHPCA Meeting was attended by 86 investigators and concentrated on many of the most promising new treatment opportunities and next-generation research technologies. Results: The topics of focus at the meeting included: new treatment strategies and novel agents for targeted therapies and precision medicine, new treatment strategies that may synergize with checkpoint immunotherapy, next-generation technologies that visualize tumor microenvironment (TME) and molecular pathology in situ, multi-omics and tumor heterogeneity using single cells, 3D and TME models, and the role of extracellular vesicles in cancer and their potential as biomarkers. Discussion: This meeting report provides a comprehensive summary of the talks and discussions held at the 2019 CHPCA Meeting, for the purpose of globally disseminating this knowledge and ultimately accelerating new treatments and diagnostics for patients with prostate cancer.

KW - artificial intelligence

KW - cancer immunotherapy

KW - precision medicine

KW - therapeutics

KW - tumor genomics

UR - http://www.scopus.com/inward/record.url?scp=85076628133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076628133&partnerID=8YFLogxK

U2 - 10.1002/pros.23934

DO - 10.1002/pros.23934

M3 - Review article

C2 - 31825540

AN - SCOPUS:85076628133

VL - 80

SP - 113

EP - 132

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 2

ER -